Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, ph... von Shapiro, Robert E., Hochstetler, Helen M., Dennehy, Ellen B., Khanna, Rashna, Doty, Erin Gautier, Berg, Paul H., Starling, Amaal J.

Volltext

Lasmiditan mechanism of action – review of a selective 5-HT1F agonist von Clemow, David B., Johnson, Kirk W., Hochstetler, Helen M., Ossipov, Michael H., Hake, Ann M., Blumenfeld, Andrew M.

Volltext

Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations von Witte, Michael M, Foster, Norman L, Fleisher, Adam S, Williams, Monique M, Quaid, Kimberly, Wasserman, Michael, Hunt, Gail, Roberts, J. Scott, Rabinovici, Gil D, Levenson, James L, Hake, Ann Marie, Hunter, Craig A, Van Campen, Luann E, Pontecorvo, Michael J, Hochstetler, Helen M, Tabas, Linda B, Trzepacz, Paula T

Volltext

Tolerability and Safety of Lasmiditan Treatment in Elderly Patients With Migraine: Post Hoc Analyses From Randomized Studies von Martin, Vincent T., Ahmed, Zubair, Hochstetler, Helen M., Baygani, Simin K., Dong, Yan, Hauck, Paula M., Khanna, Rashna

Volltext

Clinical Use of Amyloid PET Neuroimaging: Practical and Bioethical Considerations von Witte, Michael M., PhD, Foster, Norman L., MD, Fleisher, Adam S., MD, MAS, Williams, Monique M., MD, MSCI, Quaid, Kimberly, PhD, Wasserman, Michael, MD, Hunt, Gail, BA, Roberts, Scott, PhD, Rabinovici, Gil D., MD, Levenson, James L., MD, Hake, Ann M., MD, Hunter, Craig, MPP, Van Campen, Luann E., PhD, Pontecorvo, Michael J., PhD, Hochstetler, Helen M., PharmD, Trzepacz, Paula T., MD

Volltext

Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia von Degenhardt, Elisabeth K., R.N., M.S.N, Witte, Michael M., Ph.D, Case, Michael G., M.S, Yu, Peng, Ph.D, Henley, David B., M.D, Hochstetler, Helen M., Pharm.D, D’Souza, Deborah N., Ph.D., M.B.A, Trzepacz, Paula T., M.D

Volltext

DOES HIPPOCAMPAL VOLUME PREDICT POSITIVE AMYLOID STATUS ON FLORBETAPIR-PET IN HEALTHY CONTROLS AND PRODROMAL STAGES OF ALZHEIMER'S DISEASE? von Trzepacz, Paula T, Peng, Yu, Castelluccio, Peter, Hochstetler, Helen M, Joshi, Abhinay, Dell'Agnello, Grazia, Degenhardt, Elisabeth K, Selzler, Katherine J, Witte, Michael M, Devous, Michael D, Schwarz, Adam J

Volltext

Lasmiditan mechanism of action - review of a selective 5-HT 1F agonist von Clemow, David B, Johnson, Kirk W, Hochstetler, Helen M, Ossipov, Michael H, Hake, Ann M, Blumenfeld, Andrew M

Volltext

P4‐136: DOES HIPPOCAMPAL VOLUME PREDICT POSITIVE AMYLOID STATUS ON FLORBETAPIR‐PET IN HEALTHY CONTROLS AND PRODROMAL STAGES OF ALZHEIMER'S DISEASE? von Trzepacz, Paula T., Peng, Yu, Castelluccio, Peter, Hochstetler, Helen M., Joshi, Abhinay, Dell'Agnello, Grazia, Degenhardt, Elisabeth K., Selzler, Katherine J., Witte, Michael M., Devous, Michael D., Schwarz, Adam J.

Volltext

Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults von Trzepacz, Paula T, Hochstetler, Helen, Wang, Shufang, Walker, Brett, Saykin, Andrew J

Volltext

Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia von Trzepacz, Paula T, Yu, Peng, Sun, Jia, Schuh, Kory, Case, Michael, Witte, Michael M, Hochstetler, Helen, Hake, Ann

Volltext

Association Between Clinical Measures and Florbetapir F18 PET Neuroimaging in Mild or Moderate Alzheimer’s Disease Dementia von Witte, Michael M, Trzepacz, Paula, Case, Michael, Yu, Peng, Hochstetler, Helen, Quinlivan, Mitchell, Sundell, Karen, Henley, David

Volltext

Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease von Trzepacz, Paula T., Hochstetler, Helen, Yu, Peng, Castelluccio, Peter, Witte, Michael M., Dell''Agnello, Grazia, Degenhardt, Elisabeth K.

Volltext

Florbetapir positron emission tomography and cerebrospinal fluid biomarkers von Hake, Ann, Trzepacz, Paula T, Wang, Shufang, Yu, Peng, Case, Michael, Hochstetler, Helen, Witte, Michael M, Degenhardt, Elisabeth K, Dean, Robert A

Volltext

Comparison of Neuroimaging Modalities for the Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Dementia von Trzepacz, Paula, MD, Yu, Peng, PhD, Sun, Jia, MS, Schuh, Kory, PhD, Case, Michael G., MS, Witte, Michael M., PhD, Hochstetler, Helen, PharmD, Hake, Ann M., MD

Volltext

Relationship of Florbetapir F18 PET Amyloid Plaque Neuroimaging with Future Cognitive Decline over 36 Months von Hochstetler, Helen, PharmD, Doraiswamy, P. Murali, MD, Sperling, Reisa A., MD, Johnson, Keith A., MD, Reiman, Eric, MD, Sabbagh, Marwan N., MD, Sadowsky, Carl H., MD, Joshi, Abhinay D., MS, Lu, Ming, MD, Mintun, Mark A., MD, Pontecorvo, Michael J., PhD, Skovronsky, Daniel M., MD

Volltext